Imaging system has its sight set on cancerous tumours
Surgeons could receive support from a multispectral fluorescence imaging system developed by a team of researchers in Munich headed by Vasilis Ntziachristos, a professor of biological imaging.

According to a statement, a study carried out on nine patients with ovarian cancer has shown that the system can be used to localise cancer cells during surgery.
Before the operation, the patients were injected with folic acid chemically coupled to a green fluorescent dye. Most ovarian tumours have a protein molecule on their surface that bonds with folic acid and transports it inside the cell.
During abdominal surgery, the surgeon can then shine a laser light onto the patient’s ovaries, causing the green-labelled folic acid inside the cancer cells to emit light while healthy tissue remains dark. The fluorescent cancer cells, however, cannot be detected by eye.
Three cameras, mounted on a pivoting support arm over the operating table, detect optical and fluorescent signals at multiple spectral bands and then correct for light variations due to illumination and tissue discolourations in order to provide truly accurate fluorescence images that can be simultaneously displayed with corresponding colour images on monitors in the operating room.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
The EU and UK will be moving towards using Grid Forming inverters with Energy Storage that has an inherent ability to act as a source of Infinite...